Search in:

Artificial Cells, Nanomedicine, and Biotechnology

An International Journal

Volume 47, 2019 - Issue 1

Submit an article Journal homepage

Open access

1,784

Views

CrossRef citations to date

Altmetric

Retracted Article

RETRACTED ARTICLE: GLP-1 receptor agonist lixisenatide protects against high free fatty acids-induced oxidative stress and inflammatory response

Qini Zhaoa Department of Cardiovascular Medicine, China-Japan Union Hospital of Jilin University, Changchun, China;b Jilin Provincial Precision Medicine Key Laboratory for Cardiovascular Genetic Diagnosis, Changchun, China

Haiming Xua Department of Cardiovascular Medicine, China-Japan Union Hospital of Jilin University, Changchun, China

Lirong Zhangc Department of Pathology, China-Japan Union Hospital of Jilin University, Changchun, China

Long Liua Department of Cardiovascular Medicine, China-Japan Union Hospital of Jilin University, Changchun, China;b Jilin Provincial Precision Medicine Key Laboratory for Cardiovascular Genetic Diagnosis, Changchun, ChinaCorrespondence[email protected]

Libo Wangd Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, ChinaCorrespondence[email protected]

Pages 2325-2332 | Received 04 Dec 2018, Accepted 09 May 2019, Published online: 07 Jun 2019

Cite this article
https://doi.org/10.1080/21691401.2019.1620248
CrossMark

Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (10)

Ying An, Bu-tuo Xu, Sheng-rong Wan, Xiu-mei Ma, Yang Long, Yong Xu & Zong-zhe Jiang. (2023) The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction. Cardiovascular Diabetology 22:1.
Crossref

Panagiotis Theofilis, Marios Sagris, Evangelos Oikonomou, Alexios S. Antonopoulos, Gerasimos Siasos, Costas Tsioufis & Dimitris Tousoulis. (2021) Inflammatory Mechanisms Contributing to Endothelial Dysfunction. Biomedicines 9:7, pages 781.
Crossref

Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart & Jianping Weng. (2021) Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacological Reviews 73:3, pages 924-967.
Crossref

Dia Advani, Sudhanshu Sharma, Rahul Tripathi, Rohan Gupta, Asmita Jaiswal, Rashmi K. Ambasta & Pravir Kumar. 2021. Mitochondrial Dysfunction and Nanotherapeutics. Mitochondrial Dysfunction and Nanotherapeutics 91 137 .

Rania G. Abdel-latif, Amira F. Ahmed & Gehan H. Heeba. (2020) Low-dose lixisenatide protects against early-onset nephropathy induced in diabetic rats. Life Sciences 263, pages 118592.
Crossref

Agnieszka Jankowska, Anna Wesołowska, Maciej Pawłowski & Grażyna Chłoń-Rzepa. (2020) Diabetic Theory in Anti-Alzheimer’s Drug Research and Development - Part 1: Therapeutic Potential of Antidiabetic Agents. Current Medicinal Chemistry 27:39, pages 6658-6681.
Crossref

Salma N. Gad, Shahira Nofal, Eman M. Raafat & Amany A. E. Ahmed. (2020) Lixisenatide Reduced Damage in Hippocampus CA1 Neurons in a Rat Model of Cerebral Ischemia-Reperfusion Possibly Via the ERK/P38 Signaling Pathway. Journal of Molecular Neuroscience 70:7, pages 1026-1037.
Crossref

Daiji Kawanami & Yuichi Takashi. (2020) GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms. Frontiers in Pharmacology 11.
Crossref

Peng Li, Qipeng Liu, Ting Zhang, Wanying Guo, Weiqiang Qiao & Miao Deng. (2020) Protective Effects of Lixisenatide against Lipopolysaccharide-Induced Inflammation Response in MAC-T Bovine Mammary Epithelial Cells: A Therapeutic Implication in Mastitis. Chemical Research in Toxicology 33:4, pages 982-987.
Crossref

Mochao Xiao, Daifeng Lu, Jiali Tian, Yang Yu, Qin Zhang, Lili Zhang & Dong Chang. (2020) The protective effects of GLP-1 receptor agonist lixisenatide on oxygen-glucose deprivation/reperfusion (OGD/R)-induced deregulation of endothelial tube formation. RSC Advances 10:17, pages 10245-10253.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

RETRACTED ARTICLE: GLP-1 receptor agonist lixisenatide protects against high free fatty acids-induced oxidative stress and inflammatory response

Articles from other publishers (10)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

RETRACTED ARTICLE: GLP-1 receptor agonist lixisenatide protects against high free fatty acids-induced oxidative stress and inflammatory response

Citations (10)

Articles from other publishers (10)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date